Kenju Ando

451 total citations
8 papers, 96 citations indexed

About

Kenju Ando is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Kenju Ando has authored 8 papers receiving a total of 96 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Kenju Ando's work include Polyomavirus and related diseases (1 paper), Acute Myeloid Leukemia Research (1 paper) and Mast cells and histamine (1 paper). Kenju Ando is often cited by papers focused on Polyomavirus and related diseases (1 paper), Acute Myeloid Leukemia Research (1 paper) and Mast cells and histamine (1 paper). Kenju Ando collaborates with scholars based in Japan and United Kingdom. Kenju Ando's co-authors include Keiko Maeda, Takuya Kato, Atsushi Enomoto, Akitoshi Hara, Hidemi Goto, Masato Asai, Naoya Asai, Yuichi Ishikawa, Liang Weng and Shinji Mii and has published in prestigious journals such as Cancer, Scientific Reports and Journal of Biotechnology.

In The Last Decade

Kenju Ando

7 papers receiving 96 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenju Ando Japan 4 40 35 20 15 14 8 96
R Facchini United Kingdom 4 31 0.8× 31 0.9× 23 1.1× 45 3.0× 10 0.7× 5 106
Fernando Vidal‐Vanaclocha Spain 5 24 0.6× 31 0.9× 8 0.4× 14 0.9× 8 0.6× 8 67
Ingrid Furlan Germany 6 29 0.7× 69 2.0× 24 1.2× 30 2.0× 9 0.6× 13 164
Olena M. Vaske United States 7 27 0.7× 60 1.7× 19 0.9× 13 0.9× 32 2.3× 18 116
Hilary Racher Canada 3 47 1.2× 38 1.1× 7 0.3× 10 0.7× 15 1.1× 3 109
Himanshu Chheda Finland 4 29 0.7× 33 0.9× 27 1.4× 42 2.8× 7 0.5× 4 124
Petra Ketteler Germany 7 35 0.9× 25 0.7× 10 0.5× 9 0.6× 7 0.5× 23 103
Katayoon Kasaian Canada 2 25 0.6× 29 0.8× 10 0.5× 7 0.5× 16 1.1× 2 70
Mikael Johansson Sweden 4 29 0.7× 22 0.6× 28 1.4× 4 0.3× 25 1.8× 5 83
Aurore Grelier France 4 9 0.2× 41 1.2× 33 1.6× 24 1.6× 10 0.7× 6 91

Countries citing papers authored by Kenju Ando

Since Specialization
Citations

This map shows the geographic impact of Kenju Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenju Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenju Ando more than expected).

Fields of papers citing papers by Kenju Ando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenju Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenju Ando. The network helps show where Kenju Ando may publish in the future.

Co-authorship network of co-authors of Kenju Ando

This figure shows the co-authorship network connecting the top 25 collaborators of Kenju Ando. A scholar is included among the top collaborators of Kenju Ando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenju Ando. Kenju Ando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Ando, Kenju, Akihiko Shimomura, Kunihisa Tsukada, et al.. (2024). Impact of HIV status on prognosis of malignancies among people living with HIV in Japan. Cancer. 130(18). 3180–3187.
2.
Shimomura, Akihiko, et al.. (2022). Response to lenvatinib and pembrolizumab combination therapy in pembrolizumab-pretreated relapsed endometrial cancer. Gynecologic Oncology Reports. 44. 101084–101084. 6 indexed citations
3.
Ando, Kenju, et al.. (2021). A Case of Recurrent Ovarian Cancer and Therapy-Related Acute Myeloid Leukemia Treated with Azacitidine. Case Reports in Oncology. 14(3). 1847–1852. 2 indexed citations
4.
Maeda, Keiko, Atsushi Enomoto, Akitoshi Hara, et al.. (2016). Identification of Meflin as a Potential Marker for Mesenchymal Stromal Cells. Scientific Reports. 6(1). 22288–22288. 71 indexed citations
5.
Ando, Kenju, et al.. (2006). The Functional Evaluation of Future Wheelchairs Contributing to Ecological Aid in Traveling. 844–849. 5 indexed citations
6.
Nakayama, Akira, et al.. (1992). Secretion of correctly processed and folded pancreatic secretory trypsin inhibitor by Bacillus subtilis. Journal of Biotechnology. 23(2). 225–229. 3 indexed citations
7.
Oda, Yoshihisa, et al.. (1988). Optimal therapeutic regimen of famotidine based on plasma concentrations in patients with chronic renal failure.. PubMed. 10(6). 656–63. 8 indexed citations
8.
Ando, Kenju, et al.. (1971). 1. Primary Adenocarcinoma of the Vermiform Appendix. Nihon Daicho Komonbyo Gakkai Zasshi. 24(2). 67–72,104. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026